Leishmania donovanib - knocking the door.
dc.contributor.author | Kamath, S | en_US |
dc.contributor.author | Avi, H | en_US |
dc.contributor.author | Mehta, P J | en_US |
dc.date.accessioned | 1995-05-01 | en_US |
dc.date.accessioned | 2009-05-30T20:20:16Z | |
dc.date.available | 1995-05-01 | en_US |
dc.date.available | 2009-05-30T20:20:16Z | |
dc.date.issued | 1995-05-01 | en_US |
dc.identifier.citation | Kamath S, Avi H, Mehta PJ. Leishmania donovanib - knocking the door. Journal of the Association of Physicians of India. 1995 May; 43(5): 315-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/87606 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Antiprotozoal Agents --adverse effects | en_US |
dc.subject.mesh | Drug Resistance, Multiple | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immune Tolerance | en_US |
dc.subject.mesh | India | en_US |
dc.subject.mesh | Leishmania donovani --drug effects | en_US |
dc.subject.mesh | Leishmaniasis, Visceral --diagnosis | en_US |
dc.title | Leishmania donovanib - knocking the door. | en_US |
dc.type | Comment | en_US |
dc.type | Editorial | en_US |
Files
License bundle
1 - 1 of 1